logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Adrenocortical Insufficiency Chronic

    FiltersReset Filters
    5 results

    • khindivi

      (Hydrocortisone)
      Eton Pharmaceuticals, Inc.
      Usage: KHINDIVI is indicated for replacement therapy in pediatric patients aged 5 and older with adrenocortical insufficiency. It is not approved for increased dosing during stress or acute events; alternative hydrocortisone-containing products should be used for those situations.

    • methylprednisolone

      (METHYLPREDNISOLONE)
      Epic Pharma,LLC
      Usage: Methylprednisolone tablets are indicated for various conditions, including endocrine and rheumatic disorders, allergic states, dermatologic diseases, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and acute nervous system disorders, providing symptomatic relief or maintenance therapy.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate is indicated for intramuscular, intra-articular, soft tissue, or intralesional administration to treat severe allergic reactions, various dermatologic and gastrointestinal diseases, endocrine and hematologic disorders, respiratory and rheumatic conditions, as well as for palliative management of neoplastic diseases and specific nervous system and ophthalmic diseases.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, or intralesional administration to treat severe allergic conditions, dermatologic diseases, endocrine disorders, hematologic disorders, and various respiratory and rheumatic diseases, as well as for palliative care in neoplastic diseases and specific ophthalmic and renal conditions.

    • methylprednisolone sodium succinate

      (Methylprednisolone)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone sodium succinate is indicated for intravenous or intramuscular administration in severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurological conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders, especially when oral therapy is not feasible.